BioSig Technologies, Inc Stock News

Biosig Technologies Inc (BSGM) shares closed today 16.9% higher than it did at the end of yesterday. The stock is currently down 30.8% year-to-date, down 41.0% over the past 12 months, and down 59.5% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%. Trading Activity Shares traded as high as $2.70 and as low as $2.29 this week.Shares closed 56.0% below its 52-week high and 28.0% above its 52-week low.Trading volume this week was 25.5% lower than the 10-day average and 5.3% higher than the 30-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -665.9% The company's stock price performance over the past 12 months lags the peer average by -3704.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Leading healthcare management firm to enhance the Company’s market access strategy as it expands the installation base of its signal processing technology for arrhythmia care Leading healthcare management firm to enhance the Company’s market access strategy as it expands the installation base of its signal processing technology for arrhythmia care

Using targeted electrical signals to harness the body's natural mechanisms to diagnose and treat a range of diseases Has commercialized its first product, a biomedical signal processing platform call

BioSig Technologies Inc has announced the appointment of Access Strategy Partners, Inc (ASPI) to advise the company on the next phase of its commercial roll-out. BioSig said the healthcare management

BioSig Technologies Inc said that it is installing a PURE EP System for an evaluation at the Hospital Corporation of America (HCA) Healthcare-operated Westside Regional Medical Center in Plantation,

Millennium Management LLC bought a new position in BioSig Technologies, Inc. (NASDAQ:BSGM) in the second quarter, according to its most recent disclosure with the SEC. The firm bought 214,556 shares of the companys stock, valued at approximately $828,000. Millennium Management LLC owned about 0.67% of BioSig Technologies as of its most recent SEC filing. Other [] The post Millennium Management LLC Acquires New Stake in BioSig Technologies, Inc. (NASDAQ:BSGM) appeared first on ETF Daily News .

Westport, CT, Dec. 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platf

State Street Corp trimmed its position in BioSig Technologies, Inc. (NASDAQ:BSGM) by 72.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 103,773 shares of the companys stock after selling 272,380 shares during the quarter. State Street Corp owned 0.32% of BioSig []

Westport, CT, Dec. 06, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that Natasha Drapeau, Executive Vice President of BioSig Technologies, Inc., would be presenting at the Benzinga All Access event on Tuesday, December 14, 2021, at 9:40 am EST.

Northern Trust Corp decreased its holdings in BioSig Technologies, Inc. (NASDAQ:BSGM) by 71.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,462 shares of the companys stock after selling 201,193 shares during the quarter. Northern Trust Corp owned about []

Seasoned electrophysiology sales executive joins the Company to expand the commercial footprint of its signal processing technology for arrhythmia care Seasoned electrophysiology sales executive joins the Company to expand the commercial footprint of its signal processing technology for arrhythmia care

BioSig Technologies Inc has announced that Gray Fleming will be joining the company as its chief commercial officer. The Westport, Connecticut-based company said that Fleming will bring over 20 years

BioSig Technologies (NASDAQ: BSGM) is one of 65 public companies in the Electromedical equipment industry, but how does it compare to its competitors? We will compare BioSig Technologies to similar businesses based on the strength of its dividends, valuation, profitability, institutional ownership, earnings, analyst recommendations and risk. Valuation & Earnings This table compares BioSig Technologies []

BioSig Technologies (NASDAQ: BSGM) is one of 65 public companies in the Electromedical equipment industry, but how does it weigh in compared to its rivals? We will compare BioSig Technologies to related companies based on the strength of its earnings, dividends, institutional ownership, valuation, profitability, risk and analyst recommendations. Profitability This table compares BioSig Technologies []

BioSig Technologies (NASDAQ: BSGM) is one of 65 public companies in the Electromedical equipment industry, but how does it weigh in compared to its rivals? We will compare BioSig Technologies to similar businesses based on the strength of its valuation, profitability, earnings, analyst recommendations, institutional ownership, dividends and risk. Profitability This table compares BioSig Technologies []